RPTX Company Profile and Key Details

Q: Who are the executives of RPTX?

Dr. Frank Sicheri Ph.D.Co-FounderDr. Daniel Durocher Ph.D.Co-FounderDr. Michael Zinda Ph.D.Executive Vice President & Chief Scientific OfficerMr. Cameron BlackExecutive Vice President of DiscoveryMr. Philip HermanExecutive Vice President, Chief Commercial & Portfolio Devel. OfficerDr. Kim A. Seth Ph.D.Executive Vice President & Chief Bus. OfficerMr. Steve ForteExecutive Vice President & Chief Financial OfficerDr. Agnel Sfeir Ph.D.Co-FounderMr. Daniel BelangerExecutive Vice President of Human ResourceDr. Maria Koehler M.D., Ph.D.Executive Vice President & Chief Medical OfficerMr. Lloyd Mitchell SegalPres, Chief Executive Officer & Director

NASDAQ : RPTX

Repare Therapeutics

$2.55

0.38+17.51%

At Close 4:00 PM

62.32

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Repare Therapeutics Inc. (RPTX) stock surged +17.51%, trading at $2.55 on NASDAQ, up from the previous close of $2.17. The stock opened at $2.55, fluctuating between $2.54 and $2.66 in the recent session.

Stock Snapshot

2.17

Prev. Close

109.6M

Market Cap

2.54

Day Low

-1.5

P/E Ratio

-1.7

EPS (TTM)

-3.06

Cash Flow per Share

2.55

Open

42.98M

Number of Shares

2.66

Day High

71.75%

Free Float in %

5.03

Book Value

15.84M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 24, 2025	2.55	2.66	2.54	2.55	15.91M
Dec 23, 2025	2.22	2.23	2.17	2.17	241.96K
Dec 22, 2025	2.16	2.23	2.15	2.22	290.67K
Dec 19, 2025	2.16	2.18	2.14	2.14	446.15K
Dec 17, 2025	2.23	2.27	2.18	2.19	434.35K
Dec 16, 2025	2.21	2.24	2.20	2.23	295.9K
Dec 15, 2025	2.14	2.22	2.13	2.21	834.66K
Dec 12, 2025	2.15	2.18	2.13	2.14	849.39K
Dec 11, 2025	2.16	2.20	2.13	2.14	1.55M
Dec 10, 2025	2.18	2.19	2.14	2.15	809.53K
Dec 09, 2025	2.16	2.18	2.14	2.16	434.24K
Dec 08, 2025	2.22	2.22	2.15	2.15	455.44K
Dec 05, 2025	2.22	2.23	2.20	2.22	134.24K
Dec 04, 2025	2.16	2.24	2.14	2.23	382.3K
Dec 03, 2025	2.13	2.17	2.11	2.17	222.34K
Dec 02, 2025	2.13	2.15	2.12	2.13	171.8K
Dec 01, 2025	2.18	2.18	2.10	2.13	467.39K
Nov 28, 2025	2.19	2.22	2.18	2.18	128.57K
Nov 26, 2025	2.11	2.21	2.10	2.21	577.08K
Nov 25, 2025	2.12	2.15	2.11	2.12	488.17K

Contact Details

Montreal, QC H4S 2A1

Canada

https://www.reparerx.com 857 412 7018

About Company

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.

Stock Peers

ARGX

4+0.47%

argenx SE$849.95 REGN

-1.46-0.19%

Regeneron Pharmaceuticals, Inc.$783.71 MDGL

0.61+0.10%

Madrigal Pharmaceuticals, Inc.$602.82 UTHR

4.2+0.82%

United Therapeutics Corporation$514.64 VRTX

3.78+0.82%

Vertex Pharmaceuticals Incorporated$462.99 ALNY

1.99+0.50%

Alnylam Pharmaceuticals, Inc.$400.69 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-0.97-0.35%

Praxis Precision Medicines, Inc.$274.76 KRYS

-2.07-0.82%

Krystal Biotech, Inc.$251.29 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Repare Therapeutics Inc. (RPTX) stock price?

Repare Therapeutics Inc. (NASDAQ: RPTX) stock price is $2.55 in the last trading session. During the trading session, RPTX stock reached the peak price of $2.66 while $2.54 was the lowest point it dropped to. The percentage change in RPTX stock occurred in the recent session was 17.51% while the dollar amount for the price change in RPTX stock was $0.38.

RPTX's industry and sector of operation?

The NASDAQ listed RPTX is part of Biotechnology industry that operates in the broader Healthcare sector. Repare Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RPTX?

Dr. Frank Sicheri Ph.D.
Co-Founder
Dr. Daniel Durocher Ph.D.
Co-Founder
Dr. Michael Zinda Ph.D.
Executive Vice President & Chief Scientific Officer
Mr. Cameron Black
Executive Vice President of Discovery
Mr. Philip Herman
Executive Vice President, Chief Commercial & Portfolio Devel. Officer
Dr. Kim A. Seth Ph.D.
Executive Vice President & Chief Bus. Officer
Mr. Steve Forte
Executive Vice President & Chief Financial Officer
Dr. Agnel Sfeir Ph.D.
Co-Founder
Mr. Daniel Belanger
Executive Vice President of Human Resource
Dr. Maria Koehler M.D., Ph.D.
Executive Vice President & Chief Medical Officer
Mr. Lloyd Mitchell Segal
Pres, Chief Executive Officer & Director

How RPTX did perform over past 52-week?

RPTX's closing price is 186.52% higher than its 52-week low of $0.89 where as its distance from 52-week high of $2.66 is -4.13%.

How many employees does RPTX have?

Number of RPTX employees currently stands at 129.

Link for RPTX official website?

Official Website of RPTX is: https://www.reparerx.com

How do I contact RPTX?

RPTX could be contacted at phone 857 412 7018 and can also be accessed through its website. RPTX operates from 7210 Frederick-Banting, Montreal, QC H4S 2A1, Canada.

How many shares of RPTX are traded daily?

RPTX stock volume for the day was 15.84M shares. The average number of RPTX shares traded daily for last 3 months was 579.18K.

What is the market cap of RPTX currently?

The market value of RPTX currently stands at $109.60M with its latest stock price at $2.55 and 42.98M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	129
Beta	1.02
Sales or Revenue	$51.13M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	129
Beta	1.02
Sales or Revenue	$51.13M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

RPTX Company Profile and Key Details

Repare Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics